Liu M et al. presented an injectable hyaluronic-acid-based supramolecular hydrogel to improve chemo-immunotherapy in cancer by delivering the DPPA-1 peptide, a D-peptide antagonist with a high binding affinity to PD-L1, and doxorubicin (DOX). The gene discussed is CD274; the disease is cancer.